ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Elevai Labs Inc

Elevai Labs Inc (ELAB)

0.674
0.07
(11.59%)
Closed April 26 4:00PM
0.67
-0.004
(-0.59%)
After Hours: 7:22PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.67
Bid
0.659
Ask
0.6692
Volume
305,768
0.60 Day's Range 0.74
0.5709 52 Week Range 4.2442
Market Cap
Previous Close
0.604
Open
0.60
Last Trade
75
@
0.6591
Last Trade Time
Financial Volume
$ 207,242
VWAP
0.677776
Average Volume (3m)
701,401
Shares Outstanding
17,329,615
Dividend Yield
-
PE Ratio
-2.70
Earnings Per Share (EPS)
-0.25
Revenue
1.71M
Net Profit
-4.3M

About Elevai Labs Inc

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed... Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Elevai Labs Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ELAB. The last closing price for Elevai Labs was $0.60. Over the last year, Elevai Labs shares have traded in a share price range of $ 0.5709 to $ 4.2442.

Elevai Labs currently has 17,329,615 shares outstanding. The market capitalization of Elevai Labs is $11.61 million. Elevai Labs has a price to earnings ratio (PE ratio) of -2.70.

ELAB Latest News

ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months

Taiwan is ELEVAI’s third Asian contract for exosomes distribution after adding the Philippines in August of 2023 and Vietnam in May 2023 Asia-Pacific represents a combined $13 Billion prestige...

Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results

Company reports record annual revenues of $1.71 Million for 2023, up 123.5% over the previous year Company reports record Q4 2023 revenues of $698,591, up 403% from Q4 2022 NEWPORT BEACH, Calif...

Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market

ELEVAI Physician-Dispensed Skincare Now Available Direct to Consumers NEWPORT BEACH, CA -- March 18, 2024 -- InvestorsHub NewsWire -- ELEVAI LABS, INC., (NASDAQ: ELAB) a medical aesthetic...

ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office

NEWPORT BEACH, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- ELEVAI LABS, INC., (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, is pleased to announce today...

ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach

ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach NEWPORT BEACH, Calif...

ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach

NEWPORT BEACH, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- ELEVAI LABS, INC., (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, today announced certain...

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing TechnologyELEVAI Labs to commercialize use of proprietary technology designed to produce...

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology

NEWPORT BEACH, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Elevai Labs, Inc. (Nasdaq: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce it has...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.09917.33800350260.5710.740.571296930.59283295CS
4-0.044-6.162464985990.7140.740.5709517870.63426095CS
12-0.37-35.57692307691.041.04010.57097014010.78092266CS
26-3.33-83.2544.24420.57099492701.20626592CS
52-3.33-83.2544.24420.57099492701.20626592CS
156-3.33-83.2544.24420.57099492701.20626592CS
260-3.33-83.2544.24420.57099492701.20626592CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ISUNiSun Inc
$ 0.173
(84.04%)
19.85M
BRFHBarfresh Food Group Inc
$ 1.75
(69.90%)
41.45M
SGBXSafe and Green Holdings Corporation
$ 0.225
(56.14%)
132.51M
PCSAProcessa Pharmaceuticals Inc
$ 2.4137
(48.99%)
69.6M
BACKIMAC Holdings Inc
$ 5.065
(45.34%)
8.49M
EJHE Home Household Service Holdings Ltd
$ 0.767
(-73.64%)
12.36M
TVGNTevogen Bio Holdings Inc
$ 0.9057
(-39.62%)
328.69k
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.265
(-37.69%)
16.75M
ATNIATN International Inc
$ 19.24
(-33.01%)
440.2k
BNAIBrand Engagement Network Inc
$ 2.59
(-30.56%)
234.29k
SQQQProShares UltraPro Short QQQ
$ 12.00
(1.61%)
167.48M
SGBXSafe and Green Holdings Corporation
$ 0.225
(56.14%)
136.91M
TSLATesla Inc
$ 170.18
(4.97%)
126.42M
ACONAclarion Inc
$ 0.383149
(33.04%)
115.53M
TQQQProShares UltraPro QQQ
$ 52.85
(-1.60%)
86.41M

ELAB Discussion

View Posts
jelaco jelaco 2 months ago
This stock just can't stay up....someone give this pos some Viagra!
πŸ‘οΈ0
IoT II IoT II 2 months ago
https://stocktwits.com/3227blake/message/562545429
πŸ‘οΈ0
Muhbruh Muhbruh 2 months ago
$ELAB bottom chart 1.8M float no dilution and 6.6 months of cash with 22.07% 13D out today, only 20k short shares left pic.twitter.com/EFsfxgkXqv— STOCKS Gambino (@StocksGambino) February 21, 2024
πŸ‘οΈ0
Invest-in-America Invest-in-America 3 months ago
ELAB: Had skin care Patent, 1-wk. ago; maybe now an outright cure for all CANCERS??? (Joking)
πŸ‘οΈ0
IoT II IoT II 3 months ago
Goodmorning
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 months ago
and then randomly 4am .70-1.65 no news, just some more games

if it breaks 1.65 it could go

otherwise 1 & done pos pump 2.0
πŸ‘οΈ0
tw0122 tw0122 3 months ago
ELAB $1.64 just a quick premarket flip they can do all the dilution they want after 7am..lol
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 months ago
NO THX https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173636262

EVEN THOUGH i MADE A SMALL TRADE AND SOLD 1.49

ELAB IS STILL A POS IMO
πŸ‘οΈ0
tw0122 tw0122 3 months ago
Almost hit 1.30 zones 1.39- 1.60 further up
πŸ‘οΈ0
continuity continuity 3 months ago
Dilution? Total mess.
πŸ‘οΈ0
continuity continuity 3 months ago
Dilution? Total mess.
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 months ago
$ELAB MORE NEWS Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach

https://newsfilter.io/articles/elevai-labs-inc-reports-strong-preliminary-unaudited-financial-performance-for-fiscal-year-2023-high-6ea3644ed452e4ef1c28f33c0f9f63c8
πŸ‘οΈ0
airman1 airman1 3 months ago
Yes, very strange
Morning news Today the/ Shorts piled in:((

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology

ELEVAI Labs to commercialize use of proprietary technology designed to produce high-quality, cGMP grade mesenchymal stromal cells at lower-cost

NEWPORT BEACH, Calif., Jan. 16, 2024 -- InvestorsHub NewsWire -- Elevai Labs, Inc. (Nasdaq: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce it has signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio, Inc., [Nasdaq: INMB]. The licensing agreement grants Elevai a license to use INmune Bio's proprietary "EMx" technology, developed by INmune Bio, Inc., CMO, Mark Lowdell, PhD, that enables Elevai to manufacture current Good Manufacturing Practice ("cGMP") grade, human umbilical cord-derived mesenchymal stromal cells (hucMSCs) at a lower cost to Elevai than purchasing hucMSCs outright. Manufactured hucMSCs can be incorporated into certain licensed topical cosmetic products sold in the medical aesthetics skincare market.

Elevai believes incorporating the "EMx" technology into its operations is a step towards the company's goal of achieving vertical manufacturing integration, while also expanding long-term production capabilities and lowering overall costs. Ultimately, Elevai believes controlling its processes through its product pipeline with what it believes to be efficient technologies like "EMx" will allow greater stem cell consistency, purity, and propel Elevai's branded cosmetic products further to maintain the company's position as an industry innovator in the medical aesthetics skincare marke
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 months ago
SEC gives no shits

this is exactly why we 100% need Crypto, every share will be tracked every step of the way long or short

now its all a mystery, with offshore BS

cryptonize the stock market to STOP this naked shorting BS

a long time ago one senator wanted to add a serial # like a vin# to every share so companies, and shareholders could account for every share

well crypto enables exactly that, and is fully transparent on the blockchain

#THINKABOUTIT
👍️ 1
airman1 airman1 3 months ago
Classic chat pump & dump naked short
To 1.00;((
πŸ‘οΈ0
continuity continuity 3 months ago
definitely not a good way to start a business.
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 months ago
LOOKS LIKE NEWS PUMP TO DUMP SHARES IMO

https://elevaiskincare.com/
FLUFFY PUFFY SKIN ..NEWS

OVER EXTENDED POP

GAP & TRAP

BUT -11.11% IS DOWN RIGHT DISGUSTING AFTER BEING UP UP OVER 100% 4.38 HIGH

$ELAB
πŸ‘οΈ0
continuity continuity 3 months ago
this is looking very interesting. The rise is due to the acquisition. Why the fall?
πŸ‘οΈ0
IoT II IoT II 3 months ago
Hello world:)
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
Recent ipo
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock